ELLEN DOYLE: Open Payments
NPI 1174774061 · PLEASANTVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 39 payments from 7 companies in 2025. Trend: 2023 $381 · 2024 $497 · 2025 $1,638
Food & beverage: $1,559Education: $80
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $510 |
| Teva Pharmaceuticals USA, Inc. | 13 | $362 |
| Braeburn Inc. | 8 | $224 |
| Neurocrine BioSciences, Inc. | 4 | $170 |
| E.R. Squibb & Sons, L.L.C. | 3 | $135 |
| Otsuka America Pharmaceutical, Inc. | 2 | $122 |
| ABBVIE INC. | 1 | $115 |
Products named: CAPLYTA, BRIXADI, UZEDY, INGREZZA, COBENFY, VRAYLAR, REXULTI, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
